MicroStrategy
MSTR
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Coinbase
COIN
US Stock MarketDetailed Quotes
JAGX Jaguar Health
- 1.2800
- +0.2898+29.27%
Close Dec 11 16:00 ET
- 1.1900
- -0.0900-7.03%
Pre 05:28 ET
15.10MMarket Cap-0.35P/E (TTM)
1.2900High1.0000Low2.21MVolume1.0100Open0.9902Pre Close2.59MTurnover20.70%Turnover RatioLossP/E (Static)11.80MShares21.600052wk High1.11P/B13.64MFloat Cap0.900052wk Low--Dividend TTM10.66MShs Float100075500.0000Historical High--Div YieldTTM29.29%Amplitude0.9000Historical Low1.1750Avg Price1Lot Size
About Jaguar Health Company
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
Company Profile
SymbolJAGX
Company NameJaguar Health
Listing DateMay 13, 2015
Issue Price7.00
Founded2013
CEOMs. Lisa A. Conte
MarketNASDAQ
Employees49
Fiscal Year Ends12-31
Address200 Pine Street,Suite 400
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94104
Phone1-415-371-8300
Websitehttp://www.jaguar.health
Company Executives
- Name
- Position
- Salary
- Lisa A. Conte
- Chief Executive Officer, President and Director
- 815.85K
- Dr. Pravin R. Chaturvedi, PhD
- Chief Scientific Officer
- 627.13K
- Carol R. Lizak
- Chief Financial Officer and Principal Accounting Officer
- --
- Jonathan S. Wolin
- Chief of Staff, General Counsel and Chief Compliance Officer
- 562.79K
- James J. Bochnowski
- Chairman of the Board
- 140.98K
- Dr. Anula Jayasuriya, M.B.A.,M.D.,PhD
- Independent Director
- 77.61K
- Jonathan B. Siegel
- Independent Director
- 104.18K
- John Micek III JD
- Independent Director
- 101.68K
- Dr. Steven R. King, PhD
- Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary
- 491.54K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.